Guest: BBC World News year in review: How the world has become more dangerous for journalists

I was a guest on BBC World News, to talk about the state of press safety in India and the murder of senior journalist Gauri Lankesh in Bangalore.

Video: https://vimeo.com/249221978

bbc press safety anoo.png

 

Advertisements

Exclusive: Philip Morris Funded Anti-Smoking Foundation Targeting Public Health Leaders With Grants

New Delhi: I broke three stories relevant to the global health community, on the tobacco industry’s pursuit of public health leaders.

13 December 2017
“Exclusive: Philip Morris Funded Anti-Smoking Foundation Targeting Public Health Leaders With Grants”
https://thewire.in/204449/leaked-email-reveals-philip-morris-funded-anti-smoking-foundation-targeting-public-health-leaders-grants/

15 December 2017
“Public Health Leaders Ask to Be Removed From Mailing List of Foundation Offering Them Tobacco-Funded Grants”
https://thewire.in/205303/global-health-leaders-ask-to-be-removed-from-mailing-list-of-foundation-offering-them-tobacco-funded-grants/

24 December 2017
“Top Universities Reject Big Tobacco’s Research Funding While Harvard is ‘Discussing’ it”
https://thewire.in/207873/harvard-philip-morris-tobacco/

Panel: #WomenSpeakUp

Bangalore: I was invited to speak on the panel, ‘#WomenSpeakUp’ at the Orange Flower Awards in Bangalore.

If We Can Build Mangalyaan, Why Can’t We Do More in Health Sciences: New WHO Deputy Director General

New Delhi: Taking charge as WHO’s deputy director general in December, India’s Dr Soumya Swaminathan speaks to The Wire in a sixty minute interview, about global health, where India stands on medical research and how women can get ahead in the workplace.

Soumya Swaminathan: “My personal opinion is there is no scientific basis for homeopathy. And therefore, there may be people who believe the opposite but I would need to be convinced:

Transcript: https://thewire.in/200847/soumya-swaminathan-who-health-medical-research/

Video: https://t.co/d0lghCM8sO

DP39KzRVoAEyxLq.jpg

 

How the University of California Is Fighting a Proxy Patent Battle for an Expensive Cancer Drug in India

New Delhi: The university appears to be representing pharmaceutical companies Pfizer, Medivation and Astellas in its patent battle. They aren’t telling the Delhi high court this, but they do talk about it in other documents.

https://thewire.in/188045/xtandi-ucla-patent-india-cancer-drug/